Discovery and development of BMPs.
In the early 1970s, the isolation and identification of bone morphogenetic proteins (BMPs) was a major breakthrough for the understanding of the distinct biological events occurring during bone formation. Not surprising, since their discovery, BMPs have been perhaps one of the most intensively studied group of factors in various physiological processes. The prompt development of recombinant BMPs and various delivery methods made BMPs currently available for clinical use. Research and clinical studies on BMPs are ongoing, aiming to refine further our understanding of their activities in vivo and to optimise and expand their clinical use in humans.
Dimitriou
Rozalia
R
Academic Department of Trauma and Orthopaedic Surgery, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.
Giannoudis
Peter V
PV
D019485:Bone Morphogenetic Proteins / Q000502:physiology* / Q000627:therapeutic use; D001861:Bone Regeneration / Q000502:physiology*; D016503:Drug Delivery Systems; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins